Sulphorous derivatives of imidazole, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions

A compound selected from the group consisting of a compound of the formula ##STR128## wherein R.sub.1 is alkyl of 1 to 13 carbon atoms, R.sub.26 is --S--(O).sub.n --alkyl or --S(O).sub.n --phenyl, the alkyl and phenyl being optionally substituted with a member of the group consisting of --OH, alkyl, halogen, haloalkoxy, haloalkyl, alkylthio, alkoxy, alkenyl and alkynyl of up to 6 carbon atoms, phenoxy, phenylalkoxy, carbamoyl, acyl and acyloxy of an C.sub.1 -C.sub.6 -hydrocarbon organic carboxylic acid, free, salified or C.sub.1 -C.sub.4 alkyl esterified carboxy, tetrazolyl, --CN, --NO.sub.2 and mono and dialkylamino of 1 to 6 alkyl carbon atoms and phenyl optionally substituted with at least one member of the group consisting of --OH, alkyl and alkoxy of 1 to 4 carbon atoms, halogen, --CF.sub.3, free, salified or C.sub.1 -C.sub.4 alkyl esterified carboxy and tetrazolyl, n is 0, 1 or 2, R.sub.3b is selected from the group consisting of --COOC.sub.2 H.sub.5, --CH.sub.2 --O--C(CH.sub.3).sub.2 --O--CH.sub.3 and --COO--CH.sub.2 --OOC--C(CH.sub.3).sub.3, R.sup.1 is selected from the group consisting of --COOH and tetrazolyl, and their non-toxic, pharmaceutically acceptable salts with acids and bases thereof.